Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling (2022)

First Author: Porta E

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.929493

PubMed Identifier: 35910377

Publication URI: http://europepmc.org/abstract/MED/35910377

Type: Journal Article/Review

Parent Publication: Frontiers in Pharmacology

ISSN: 1663-9812